| Date Filed | Type | Description |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/12/2022 |
3
| Patel Nilesh Umedbhai (Director) has filed a Form 3 on MARIZYME INC |
| 06/09/2022 |
4
| STEWART MICHAEL R (Director) has filed a Form 4 on MARIZYME INC|
Txns:
| Granted 120,000 options to buy
@ $2.2, valued at
$264k
|
|
| 06/09/2022 |
4
| Brostowin Terry A (Director) has filed a Form 4 on MARIZYME INC|
Txns:
| Granted 40,000 options to buy
@ $2.2, valued at
$88k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Kampf Julie B. (Director) has filed a Form 4 on MARIZYME INC|
Txns:
| Granted 40,000 options to buy
@ $2.2, valued at
$88k
|
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/01/2022 |
3
| STEWART MICHAEL R (Director) has filed a Form 3 on MARIZYME INC |
| 03/21/2022 |
4
| Ross Harrison (Vice President of Finance) has filed a Form 4 on MARIZYME INC|
Txns:
| Granted 273,750 options to buy
@ $1.01, valued at
$276.5k
|
|
| 03/18/2022 |
4
| Kovalyov Georgiy (CFO) has filed a Form 4 on MARIZYME INC|
Txns:
| Granted 273,750 options to buy
@ $1.01, valued at
$276.5k
|
|
| 02/09/2022 |
4
| Barthel David (CEO) has filed a Form 4 on MARIZYME INC|
Txns:
| Disposed/sold 400,000 options to buy
@ $2.25, valued at
$900k
Granted 400,000 options to buy
@ $1.75, valued at
$700k
|
|
| 01/13/2022 |
3
| Kovalyov Georgiy (CFO) has filed a Form 3 on MARIZYME INC |
| 01/13/2022 |
3
| Ross Harrison (Vice President of Finance) has filed a Form 3 on MARIZYME INC |
| 01/13/2022 |
3
| Richmond Bradley (Acting VP of Finance) has filed a Form 3 on MARIZYME INC |
| 01/06/2022 |
3
| Barthel David (CEO) has filed a Form 3 on MARIZYME INC |
| 03/31/2021 |
4
| Brostowin Terry A (Director) has filed a Form 4 on MARIZYME INC|
Txns:
| Granted 125,000 options to buy
@ $1.25, valued at
$156.3k
|
|
| 03/23/2021 |
4
| SAPIRSTEIN JAMES (Interim CEO) has filed a Form 4 on MARIZYME INC|
Txns:
| Granted 125,000 options to buy
@ $1.25, valued at
$156.3k
|
|
| 03/17/2021 |
3
| Dhaduk Vithalbhai D (Director) has filed a Form 3 on MARIZYME INC |
| 03/17/2021 |
3
| Kampf Julie B. (Director) has filed a Form 3 on MARIZYME INC |
| 12/22/2020 |
3
| Brooks Steven Scott (Chief Medical Officer) has filed a Form 3 on MARIZYME INC |
| 12/07/2020 |
3
| Very Donald Leroy JR (Executive Vice President) has filed a Form 3 on MARIZYME INC |
| 12/03/2020 |
3
| CAMPBELL NEIL J (CEO) has filed a Form 3 on MARIZYME INC |
| 11/16/2020 |
4
| Harmon Bruce (CFO) has filed a Form 4 on MARIZYME INC|
Txns:
| Granted 120,000 options
@ $1.25, valued at
$150k
|
|
| 11/16/2020 |
3
| Chandrasekhar Satishchandran (COO) has filed a Form 3 on MARIZYME INC |
| 11/16/2020 |
3
| Pachuk Catherine J. (Chief Science Officer) has filed a Form 3 on MARIZYME INC |
| 09/10/2020 |
3
| SAPIRSTEIN JAMES (Interim Chief Executive Office) has filed a Form 3 on MARIZYME INC |
| 09/10/2020 |
3
| Brostowin Terry A (Director) has filed a Form 3 on MARIZYME INC |
| 09/10/2020 |
3
| Harmon Bruce (CFO) has filed a Form 3 on MARIZYME INC |
| 10/28/2019 |
3
| DeVito Nicholas (Interim CEO, Interim CFO) has filed a Form 3 on MARIZYME INC |
| 12/11/2018 |
3
| Schleipfer-Conley Emmanuelle (10% Owner) has filed a Form 3 on MARIZYME INC |
| 12/11/2018 |
3
| Gutierrez Juan Francisco (Director) has filed a Form 3 on MARIZYME INC |
|